# reload+after+2024-01-23 19:45:27.046908
address1§Three Columbus Circle
address2§15th Floor
city§New York
state§NY
zip§10019
country§United States
phone§646 427 2727
website§https://indaptusrx.com
industry§Biotechnology
sector§Healthcare
longBusinessSummary§Indaptus Therapeutics, Inc., a clinical biotechnology company, develops various anti-cancer and anti-viral immunotherapy products. Its lead clinical candidate is Decoy20 used to produce single agent activity and/or combination therapy-based durable responses of lymphoma, hepatocellular, colorectal, and pancreatic tumors, as well as chronic hepatitis B virus and human immunodeficiency virus infection, which is in Phase 2 clinical trial. The company was formerly known as Intec Parent, Inc. and changed its name to Indaptus Therapeutics, Inc. in August 2021. Indaptus Therapeutics, Inc. is headquartered in New York, New York.
fullTimeEmployees§6
companyOfficers§[{'maxAge': 1, 'name': 'Mr. Jeffrey A. Meckler', 'age': 56, 'title': 'CEO & Director', 'yearBorn': 1967, 'fiscalYear': 2022, 'totalPay': 888322, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Walt Addison Linscott Esq.', 'age': 62, 'title': 'Chief Operating Officer', 'yearBorn': 1961, 'fiscalYear': 2022, 'totalPay': 666630, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Michael J. Newman Ph.D.', 'age': 67, 'title': 'Founder, Chief Scientific Officer & Director', 'yearBorn': 1956, 'fiscalYear': 2022, 'totalPay': 468821, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Nir  Sassi', 'age': 47, 'title': 'CFO, Secretary & Treasurer', 'yearBorn': 1976, 'fiscalYear': 2022, 'totalPay': 378467, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Roger J. Waltzman M.B.A., M.D.', 'age': 55, 'title': 'Chief Medical Officer', 'yearBorn': 1968, 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}]
compensationAsOfEpochDate§1672444800
maxAge§86400
priceHint§4
payoutRatio§0.0
beta§1.047
currency§USD
dateShortInterest§1702598400
forwardEps§-1.73
exchange§NCM
quoteType§EQUITY
shortName§Indaptus Therapeutics, Inc.
longName§Indaptus Therapeutics, Inc.
firstTradeDateEpochUtc§1438695000
timeZoneFullName§America/New_York
timeZoneShortName§EST
uuid§a1d498dc-072a-31b7-a80f-484137d2b2e5
gmtOffSetMilliseconds§-18000000
targetHighPrice§12.0
targetLowPrice§8.0
targetMeanPrice§10.0
targetMedianPrice§10.0
recommendationMean§2.0
recommendationKey§buy
numberOfAnalystOpinions§2
quickRatio§6.75
grossMargins§0.0
ebitdaMargins§0.0
trailingPegRatio§None
